Therapeutic communities: AIDS/HIV risk and harm reduction |
| |
| Institution: | 1. Stem Cell Arts, 5550 Friendship Blvd, Chevy Chase, MD 20815, USA;2. Centeno Schultz Clinic, 403 Summit Blvd, Suite 201, Broomfield, CO 80021, USA;1. Department of Biostatistics, University of Alabama at Birmingham, AL 35294, USA;2. Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322, USA;3. McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA;4. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA;1. Laboratoire de Mathématiques de Besançon, Université Bourgogne Franche-Comté et CNRS (UMR 6623), 16 route de Gray, 25030 Besançon cédex, France;2. Division of Mathematical Sciences, School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore;1. Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 14176, Iran;2. Chemistry and Chemical Engineering Research Center of Iran (CCERCI), P.O. BOX 14335-186, Tehran, Iran;3. Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran;4. Neurobiomedical Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran;5. Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran |
| |
| Abstract: | The limited survey data available suggest that therapeutic communities have increasingly organized themselves to develop HIV prevention programs and to integrate HIV-infected and AIDS clients into the treatment community while providing specialized program as necessary. Nonetheless, there remains a need for a comprehensive survey of the response of therapeutic communities to AIDS and the risk of HIV infection. There is need as well for studies that can build on findings linking retention in the therapeutic community to strategies that focus on clients' motivation or readiness for treatment. In addition, therapeutic community programs can ally with outreach programs both to provide priority admission to seropositive clients, women with children, adolescents, and criminal justice clients, and to provide harm reduction services to those unwilling to enter treatment while also taking incremental steps to engage those clients in ever increasing behavior change initiatives. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
